Glenmark Life Sciences Stock Declines by -5.31% on October 22, Rated as 'Hold' by MarketsMOJO

Glenmark Life Sciences, a midcap pharmaceutical company, has seen a decline in its stock price by -5.31% on October 22, 2024. This decline has been reflected in the stock call given by MarketsMOJO, which has rated the stock as 'Hold'.

The stock has underperformed the sector by -4.08% and has been on a consecutive fall for the last 5 days, with a total decline of -12.44% during this period. On October 22, the stock touched an intraday low of Rs 1051.2, which is a decrease of -5.47% from the previous day's closing price.

While the stock's performance today has been lower than the sector, it is still higher than its 100 day and 200 day moving averages. However, it is currently lower than its 5 day, 20 day, and 50 day moving averages.

In comparison to the Sensex, Glenmark Life Sciences' 1 day performance has been -5.05%, while the Sensex has only seen a decline of -0.75%. Similarly, the stock's 1 month performance has been -8.03%, while the Sensex has only seen a decline of -4.73%.

Overall, Glenmark Life Sciences' stock has seen a decline in its performance, but it is still performing better than the Sensex. Investors should keep an eye on the stock's performance in the coming days to make informed decisions.